To complete this assignment, use the Internet and Strayer databases and recall your readings in Chapter 11 of Introduction to Epidemiology and Chapter 7 of Epidemiology for Public Health Practice.
Write a 5–6 page paper in which you do the following:
Through cohort study designs and other evidence-based management studies, identify the major causes of cardiovascular disease and analyze the key steps, including current medications, used to address the disease.
Develop at least five leading questions that may be posed to the local health department in regard to mitigating the proliferation of the disease. Provide a sound rationale for raising these questions.
Based on the five questions developed in Question 2, provide a rudimentary protocol to disseminate this information to local community leaders.

Recommend six steps that may be given to current or previous place of employment to prevent the proliferation of CVD. Provide support for recommendations.
Use at least six peer-reviewed academic resources in this assignment. These must come from journal sources. Note: Fact Sheets, Wikipedia, and nonacademic websites do not qualify as academic resources.
This course requires the use of Strayer Writing Standards. For assistance and information, please refer to the Strayer Writing Standards link in the left-hand menu of your course. Check with your faculty for any additional instructions.
The specific course learning outcome associated with this assignment is:
Recommend steps for preventing the proliferation of a disease, based on research findings.

Introduction
Increasingly, the public health field has recognized the importance of screening programs for the secondary prevention of morbidity and mortality. Efforts to control diseases by early detection through screening have led to a basic change in the nature of medical practice from an exclusive focus upon a small number of ill persons to a targeting of large numbers of asymptomatic persons.1 At the same time, patients and healthcare providers alike find recommendations for use of screening tests such as the prostate-specific antigen (PSA) test and screening mammography to be confusing.
Screening programs for coronary heart disease risk factors have incited the public’s awareness of hypertension control and dietary components of hypercholesterolemia. Breast cancer screening by mammography for early malignancies combined with effective cancer therapies have contributed to the high 5-year survival rates for this cancer site. According to research findings, breast cancer screening is efficacious for women 50 years of age and older. Exhibit 11–1 describes one opinion regarding the current debate over the effectiveness of screening women who are in the 40- to 49-year-old age group. This chapter discusses screening for disease in the population, including reliability and validity of measures, concepts and terminology of screening, sensitivity, and specificity as well as positive and negative predictive values.

EXHIBIT 1 Should Women Aged 40 Through 49 Years Receive Routine Mammography Screening?